We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Current good manufacturing practice requirements for combination products

23 January 2017

Washington, DC

Medical Device and Pharmaceutical/Biotech Alert

On January 11, 2017, the U.S. Food and Drug Administration (FDA) issued a final guidance document entitled “Current Good Manufacturing Practice Requirements for Combination Products.”[1] This guidance describes and explains the agency’s January 22, 2013 final rule on current good manufacturing practice (CGMP) requirements for combination products (the Final Rule).[2]

Largely adhering to a January 2015 draft guidance that was put out for comment, the final guidance provides:

  • A discussion regarding the definition of a “combination product
  • An overview of the Final Rule
  • A description of the agency’s review of combination product CGMP issuesGeneral considerations for CGMP compliance and requirements for combination products. 

Read more for further details.


Loading data